We are live on ! Find out more
LDRS

Innovator IBD ETF Leaders ETF

Delisted

LDRS was delisted on the 13th of August, 2021.

10 hedge funds and large institutions have $2.29M invested in Innovator IBD ETF Leaders ETF in 2019 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

42% more capital invested

Capital invested by funds: $1.61M → $2.29M (+$672K)

11% more funds holding

Funds holding: 910 (+1)

60% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 5

Holders
10
Holders Change
+1
Holders Change %
+11.11%
% of All Funds
0.2%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
2
Reduced
5
Closed
1
Calls
Puts
Net Calls
Net Calls Change

LDRS Hedge Fund Activity: Q4 2019 in Review

10 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Innovator IBD ETF Leaders ETF (LDRS) for Q4 2019, worth a combined $2.29M — up 42% from $1.61M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new LDRS positions and 1 closed out — a net gain of 1 holder — while 2 added to existing stakes and 5 trimmed.

The largest buyer was Susquehanna International Group, adding an estimated $521K. The largest seller was Citadel Advisors, cutting an estimated $203K.

  • 10 institutional investors held Innovator IBD ETF Leaders ETF (LDRS) as of Q4 2019, up from 9 in Q3 2019.
  • Funds reported $2.29M of Innovator IBD ETF Leaders ETF stock for Q4 2019, up 42% quarter-over-quarter.
  • 2 funds opened new Innovator IBD ETF Leaders ETF positions in Q4 2019 and 1 closed out, a net change of +1 holder.
  • The largest Innovator IBD ETF Leaders ETF buyer in Q4 2019 was Susquehanna International Group, an estimated $521K added.
  • The largest Innovator IBD ETF Leaders ETF seller in Q4 2019 was Citadel Advisors, an estimated $203K sold.

Based on aggregated 13F filings for Q4 2019.